Practices of Accompaniment of the Relatives of Patients in the AGonic Phase by an Interdisciplinary Team (PROPAGE2)

January 15, 2024 updated by: University Hospital, Bordeaux

Practices of Accompaniment of the Relatives of Patients in the Agonic Phase by an Interdisciplinary Team

The PROPAGE study program aims above all to improve the experience and satisfaction of family and friends regarding the support they receive during the dying person's agony phase.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The objective of PROPAGE 2 is to establish a consensus on the practices for accompanying relatives during the agonic phase in the context of hospitalization in the palliative care unit by an interdisciplinary team.

Study Type

Observational

Enrollment (Actual)

278

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Nîmes, France
        • CHU de Nîmes

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Sampling Method

Probability Sample

Study Population

This includes people working in a palliative care unit as well as relatives who have known a patient in agony phase in a palliative care unit.

Description

INCLUSION CRITERIA

  1. PALLIATIVE CARE UNITS (USP) 35 palliative care unit will be drawn at random among the 164 French palliative care unit (www.sfap.org). In the event of refusal of participation, the drawing of lots will continue until 35 participating palliative care unit are obtained. The inclusion criteria for palliative care units were determined from the survey carried out in 2013 by the National End of Life Observatory on palliative care units in France. In order for there to be representativeness, the status of the palliative care unit will be taken into account from the national University Hospital (CHU) distribution, excluding CHU in the public sector, private non-profit sector, private for-profit sector. Thus, out of the 35 palliative care units: 7 will be within CHU, 16 will be outside CHU in the public sector, 7 will be in the private non-profit sector, and 5 in the private for-profit sector (criteria determined from the survey of the National End of Life Observatory in 2013) by ensuring that there are no more than 3 palliative care units in the same department (this in order to avoid that a geographical territory is over-represented, which would be liable to bias the results).

    In the event of refusal of a palliative care units or of inadequacy of the criteria, the drawing of lots will be continued until 35 participating USPs are obtained.

    Each team of these palliative care units must allow the participation of 7 experts: 1 for each group of experts, i.e. 5 socio-health professionals working in all the palliative care units (doctors, psychologists, nursing assistants, nurses, socio-educational assistant) as well as the coordinator of support volunteers and a relative by palliative care unit.

  2. THE EXPERTS

6 volunteer experts who will participate in the panel of voters: a doctor (group 1), an IDE ( group 2), an AS (group 3), a psychologist (group 4), an ASE (group 5), a volunteer support coordinator (group 6) . A relative (group 7) will be done.

The inclusion criteria:

  • For professionals, at least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit.
  • For volunteers, at least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit. The representative participating in the study will preferably be the volunteer coordinator.
  • For relatives Relative of a patient who died in the palliative care unit at least 6 months ago Person to trust or to prevent if not designated Relative understanding and speaking sufficient French Relative not a health professional

Relative who visited the palliative care unit during the last 3 days of the patient's life and who met the care team:

  • Traceability of the arrival of the loved one in the last 2/3 days of the patient's hospitalization
  • Traceability of a meeting of the loved one with a member of the team over the last 3 days of his hospitalization or verification during telephone contact with the loved one after drawing lots Relative with an email address (to be verified during telephone contact with the loved one after drawing lots)

NO-INCLUSION AND EXCLUSION CRITERIA

  1. PALLIATIVE CARE UNITS Palliative care unit who could not be represented by the 7 experts required

    • Have participated in the PROPAGE 1 study
    • Have taken part in the questionnaire test.
  2. THE EXPERTS Palliative care unit Experts: Anyone with less than 3 years of palliative care unit experience.

Relatives:

Relative of a patient who died in the palliative care unit less than 6 months ago Relative not understanding and not speaking French enough Relative being a health professional Relative who has not been to the palliative care unit in the last 3 days of the patient's life Relative who does not have an email address (to be checked during telephone contact with the loved one after drawing lots).

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Physician
at least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit.
a questionnaire consisting of a list of support practices
Psychologists
at least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit.
a questionnaire consisting of a list of support practices
Caregivers
at least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit.
a questionnaire consisting of a list of support practices
Nurses
at least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit.
a questionnaire consisting of a list of support practices
Social and Educational Assistants
at least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit.
a questionnaire consisting of a list of support practices
Volunteers
at least 3 years of seniority in palliative care unit will be required, including 1 year in the participating palliative care unit. The representative participating in the study will preferably be the volunteer coordinator.
a questionnaire consisting of a list of support practices
Relatives

Relative of a patient who died in the palliative care unit at least 6 months ago Person to trust or to prevent if not designated Relative understanding and speaking sufficient French Relative not a health professional

Relative who visited the palliative care unit during the last 3 days of the patient's life and who met the care team:

  • Traceability of the arrival of the loved one in the last 2/3 days of the patient's hospitalization
  • Traceability of a meeting of the loved one with a member of the team over the last 3 days of his hospitalization or verification during telephone contact with the loved one after drawing lots Relative with an email address (to be verified during telephone contact with the loved one after drawing lots)
a questionnaire consisting of a list of support practices

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Score of Likert-type scales (rated between 0 and 9), best match what each participant think about support practices for relatives of persons in the agony phase : from 1 (strongly disagree) to 9 (strongly agree).
Time Frame: Day 1
It is based on a questionnaire made up of a list of support practices developed from the literature review and the list of practices identified through focus groups in the preliminary study PROPAGE 1. The responses are collected. on Likert-type scales reflecting the degree of agreement towards a proposition (rated between 0 and 9) and / or in the form of free comments.
Day 1
Score of Likert-type scales (rated between 0 and 9), best match what each participant think about support practices for relatives of persons in the agony phase : from 1 (strongly disagree) to 9 (strongly agree).
Time Frame: Month 2
It is based on a questionnaire made up of a list of support practices developed from the literature review and the list of practices identified through focus groups in the preliminary study PROPAGE 1. The responses are collected. on Likert-type scales reflecting the degree of agreement towards a proposition (rated between 0 and 9) and / or in the form of free comments.
Month 2
Score of Likert-type scales (rated between 0 and 9), best match what each participant think about support practices for relatives of persons in the agony phase : from 1 (strongly disagree) to 9 (strongly agree).
Time Frame: Month 4
It is based on a questionnaire made up of a list of support practices developed from the literature review and the list of practices identified through focus groups in the preliminary study PROPAGE 1. The responses are collected. on Likert-type scales reflecting the degree of agreement towards a proposition (rated between 0 and 9) and / or in the form of free comments.
Month 4

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Carole ROUMIGUIERE, University Hospital, Bordeaux

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2021

Primary Completion (Actual)

May 15, 2022

Study Completion (Actual)

May 15, 2022

Study Registration Dates

First Submitted

March 25, 2021

First Submitted That Met QC Criteria

March 25, 2021

First Posted (Actual)

March 26, 2021

Study Record Updates

Last Update Posted (Actual)

January 17, 2024

Last Update Submitted That Met QC Criteria

January 15, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • CHUBX 2019/60

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Practice Nurse's Scope

Clinical Trials on questionnaire

Subscribe